TY - JOUR AU - Kumar, Princy AU - DeJesus, Edwin AU - Huhn, Gregory AU - Sloan, Louis AU - Small, Catherine Butkus AU - Edelstein, Howard AU - Felizarta, Franco AU - Hao, Ritche AU - Ross, Lisa AU - Stancil, Britt AU - Pappa, Keith AU - Ha, Belinda AU - for the SUPPORT Study Team PY - 2013 DA - 2013/06/07 TI - Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results JO - BMC Infectious Diseases SP - 269 VL - 13 IS - 1 AB - Rates of cardiovascular disease are higher among HIV-infected patients as a result of the complex interplay between traditional risk factors, HIV-related inflammatory and immunologic changes, and effects of antiretroviral therapy (ART). This study prospectively evaluated changes in cardiovascular biomarkers in an underrepresented, racially diverse, HIV-1-infected population receiving abacavir/lamivudine as backbone therapy. SN - 1471-2334 UR - https://doi.org/10.1186/1471-2334-13-269 DO - 10.1186/1471-2334-13-269 ID - Kumar2013 ER -